XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Net Income Per Share, Basic and Diluted
The details of basic and diluted net income (loss) per share are as follows:
Three Months EndedNine Months Ended
September 30,September 30,
2022202120222021
Numerator:
Net income (loss)
$36,997 $(48,022)$149,058 $54,611 
Less: Net income (loss) attributable to participating securities
(11)(3)(31)(6)
Net income (loss) attributable to Class A and Class B common stockholders, basic
36,986 (48,025)149,027 54,605 
Add: Interest expense, net of tax, attributable to assumed conversion of convertible senior notes832 — 
(1)
5,116 — 
Net income (loss) attributable to Class A and Class B common stockholders, diluted
$37,818 $(48,025)$154,143 $54,605 
Denominator:
Weighted average shares, basic310,116,104 308,195,379 308,959,801 305,119,985 
Dilutive effect of stock options, restricted stock, and RSUs4,126,936 — 5,278,839 9,430,643 
Dilutive effect of ESPP168,518 — 171,571 107,508 
Dilutive effect of assumed conversion of convertible senior notes10,758,825 — 17,667,623 — 
Weighted average shares, diluted325,170,383 308,195,379 332,077,834 314,658,136 
Net income (loss) per share, basic
$0.12 $(0.16)$0.48 $0.18 
Net income (loss) per share, diluted
$0.12 $(0.16)$0.46 $0.17 
(1)The effect of interest expense, net of tax, attributable to assumed conversion of convertible senior notes for the three months ended September 30, 2021 has been excluded from the calculation of diluted net loss per share due to the net loss for the period.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potential common shares were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their effect would have been anti‑dilutive for the periods presented:
Three Months EndedNine Months Ended
September 30,September 30,
2022202120222021
RSUs297,789 8,174,124 279,789 90,400 
ESPP— 97,804 — — 
Convertible senior notes6,908,798 17,667,623 — 12,076,899 
Total anti-dilutive securities7,206,587 25,939,551 
(1)
279,789 12,167,299 
(1)The effect of dilutive securities for the three months ended September 30, 2021 have been excluded from the calculation of diluted net loss per share as those potential common shares would have been anti‑dilutive due to the net loss for the period, except for 90,400 RSUs that were anti‑dilutive under the two‑class method calculation of diluted net income (loss) per share.